5,5'-Dimethoxylariciresinol 4-O-glucosideCAS# 154418-16-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 154418-16-3 | SDF | Download SDF |
| PubChem ID | 91884978 | Appearance | Powder |
| Formula | C28H38O13 | M.Wt | 582.6 |
| Type of Compound | Lignans | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S,3R,4S,5S,6R)-2-[4-[4-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2,6-dimethoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
| SMILES | COC1=CC(=CC(=C1O)OC)CC2COC(C2CO)C3=CC(=C(C(=C3)OC)OC4C(C(C(C(O4)CO)O)O)O)OC | ||
| Standard InChIKey | OSPNTYPNEPEMIS-PQDWNSJOSA-N | ||
| Standard InChI | InChI=1S/C28H38O13/c1-35-17-6-13(7-18(36-2)22(17)31)5-15-12-39-26(16(15)10-29)14-8-19(37-3)27(20(9-14)38-4)41-28-25(34)24(33)23(32)21(11-30)40-28/h6-9,15-16,21,23-26,28-34H,5,10-12H2,1-4H3/t15?,16?,21-,23-,24+,25-,26?,28+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. 5,5'-Dimethoxylariciresinol-4'-O-beta-D-glucoside is shown to effectively enhance chemosensitivity of resistant cells, which makes it may be a suitable candidate for potential multidrug resistance (MDR)-reversing agents. |
5,5'-Dimethoxylariciresinol 4-O-glucoside Dilution Calculator
5,5'-Dimethoxylariciresinol 4-O-glucoside Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.7164 mL | 8.5822 mL | 17.1644 mL | 34.3289 mL | 42.9111 mL |
| 5 mM | 0.3433 mL | 1.7164 mL | 3.4329 mL | 6.8658 mL | 8.5822 mL |
| 10 mM | 0.1716 mL | 0.8582 mL | 1.7164 mL | 3.4329 mL | 4.2911 mL |
| 50 mM | 0.0343 mL | 0.1716 mL | 0.3433 mL | 0.6866 mL | 0.8582 mL |
| 100 mM | 0.0172 mL | 0.0858 mL | 0.1716 mL | 0.3433 mL | 0.4291 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Methyl 3-O-feruloylquinate
Catalog No.:BCN3403
CAS No.:154418-15-2
- Capecitabine
Catalog No.:BCN2168
CAS No.:154361-50-9
- Echistatin, α1 isoform
Catalog No.:BCC5988
CAS No.:154303-05-6
- CB-5083
Catalog No.:BCC6528
CAS No.:1542705-92-9
- Ampalex
Catalog No.:BCC1359
CAS No.:154235-83-3
- Abiraterone
Catalog No.:BCC2259
CAS No.:154229-19-3
- Abiraterone Acotate
Catalog No.:BCN2184
CAS No.:154229-18-2
- Clasto-Lactacystin β-lactone
Catalog No.:BCC1224
CAS No.:154226-60-5
- N-[2-Isopropylthiazol-4-ylmethyl(methyl)carbamoyl]-L-valine
Catalog No.:BCC9067
CAS No.:154212-61-0
- YM 90K hydrochloride
Catalog No.:BCC7455
CAS No.:154164-30-4
- DMAB-anabaseine dihydrochloride
Catalog No.:BCC7301
CAS No.:154149-38-9
- PD 144418 oxalate
Catalog No.:BCC7429
CAS No.:154130-99-1
- Zinc protoporphyrin IX
Catalog No.:BCC6775
CAS No.:15442-64-5
- Lysicamine
Catalog No.:BCN6523
CAS No.:15444-20-9
- Pramanicin
Catalog No.:BCN1853
CAS No.:154445-05-3
- Fmoc-Arg(Pbf)-OH
Catalog No.:BCC3040
CAS No.:154445-77-9
- NU 7026
Catalog No.:BCC3933
CAS No.:154447-35-5
- LY 294002
Catalog No.:BCC3659
CAS No.:154447-36-6
- LY 303511
Catalog No.:BCC1715
CAS No.:154447-38-8
- Methyl 5-O-feruloylquinate
Catalog No.:BCN3402
CAS No.:154461-64-0
- Sinapaldehyde glucoside
Catalog No.:BCN1689
CAS No.:154461-65-1
- CHM 1
Catalog No.:BCC2387
CAS No.:154554-41-3
- SB 204990
Catalog No.:BCC6342
CAS No.:154566-12-8
- Stauprimide
Catalog No.:BCC7768
CAS No.:154589-96-5
Reversal of multidrug resistance by 5,5'-dimethoxylariciresinol-4-O-beta-D-glucoside in doxorubicin-resistant human leukemia K562/DOX.[Pubmed:24347768]
Indian J Pharmacol. 2013 Nov-Dec;45(6):597-602.
OBJECTIVE: The objective of this study was to investigate the reversal effects of 5,5'-dimethoxylariciresinol-4'-O-beta-D-glucoside (DMAG) extracted from traditional Chinese medicines Mahonia on multidrug resistance (MDR) of human leukemia cells to chemotherapeutic agents. MATERIALS AND METHODS: MTT(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was performed to determine the effect of DMAG on doxorubicin sensitivity to K562/DOX cells. Propidium iodide /Hoechst 33342 double staining assay was used to investigate the effect of DMAG on doxorubicin-induced cellular apoptosis. Intracellular accumulation of doxorubicin and rhodamine 123 assay were performed to evaluate the effect of DMAG on drugs efflux activity of P-glycoprotein. RESULTS: DMAG significantly enhanced the doxorubicin cytotoxicity to K562/DOX cells. In the presence of 1.0 muM of DMAG, the IC50 of doxorubicin decreased from 34.93 +/- 1.37 muM to 12.51 +/- 1.28 muM. DMAG of 1.0 muM significantly enhanced doxorubicin-induced cell apoptosis in K562/DOX cells and the enhancement was time-dependent. A significant increase in accumulation of doxorubicin in the presence of DMAG was observed. After treatment of the K562/DOX cells for 1 h with 15.0 muM doxorubicin alone, the fluorescence intensity was 33093.12. With the addition of 1.0 muM of DMAG, the fluorescence intensity of doxorubicin was 2.3-fold higher. A significant increase of accumulation of rhodamine 123 in the presence of DMAG was also observed. With the addition of 1.0 muM of DMAG, the fluorescence intensity was increased by 49.11% compared with rhodamine 123 alone. CONCLUSION: DMAG was shown to effectively enhance chemosensitivity of resistant cells, which makes it might be a suitable candidate for potential MDR-reversing agents.
